Results 1 to 10 of about 24,763,168 (195)
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series [PDF]
Journal of Asthma and Allergy, 2021 Eleonora Nucera,1 Sara Urbani,1 Alessandro Buonomo,1 Tiziana De Pasquale,2 Angela Rizzi,1 Arianna Aruanno,1 Stefano Pucci2 1Allergy Unit, Fondazione Policlinico Universitario A.
Nucera E +6 more
doaj +9 more sources
Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications [PDF]
Nanomaterials, 2021 Gadolinium (Gd) based contrast agents (CAs) (Gd-CAs) represent one of the most advanced developments in the application of Gd for magnetic resonance imaging (MRI). Current challenges with existing CAs generated an urgent requirement to develop multimodal
Atiya Fatima +5 more
doaj +4 more sources
Electrochemical Method for the Design of New Possible Gadolinium-Based Contrast Agents [PDF]
NanomaterialsMagnetic resonance imaging (MRI) is a technique that employs strong magnetic fields and radio frequencies to generate detailed images of the body’s interior.
Claudia Carbone +6 more
doaj +4 more sources
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review [PDF]
International Journal of Molecular SciencesGadolinium-based contrast agents (GBCAs) have been used for more than 30 years to improve magnetic resonance imaging, a crucial tool for medical diagnosis and treatment monitoring across multiple clinical settings. Studies have shown that exposure to GBCAs is associated with gadolinium release and tissue deposition that may cause short- and long-term ...
Maria João Valente +2 more
exaly +5 more sources
A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents [PDF]
Renal Failure, 2022 Objective This is the first study to explore the risk factors for nephropathy caused by gadolinium-based contrast agents and establish a prediction model to identify high-risk patients.Methods A total of 1404 patients who received gadolinium-based ...
Huanhuan Zheng +5 more
doaj +2 more sources
Hepatobiliary MR imaging with gadolinium-based contrast agents† [PDF]
Journal of Magnetic Resonance Imaging, 2012 AbstractThe advent of gadolinium‐based “hepatobiliary” contrast agents offers new opportunities for diagnostic magnetic resonance imaging (MRI) and has triggered great interest for innovative imaging approaches to the liver and bile ducts. In this review article we discuss the imaging properties of the two gadolinium‐based hepatobiliary contrast agents
Elmar Merkle, Scott K Nagle, Neil Rofsky
exaly +3 more sources
Gadolinium-based contrast agents in neurofibromatosis type 1 (Review). [PDF]
Exp Ther Med, 2021 Gadolinium (symbol Gd) is the chemical element with atomic number 64 and is aductile rare-earth metal, and +3 is its most frequent oxidation state. Gadolinium has an ionic radius of 0.99 Å and is nearly identical to the one of Ca2+. Gd3+ and Ca2+ can become toxic to biological systems if complete.
Năstase F +8 more
europepmc +4 more sources
Gadolinium-Based Contrast Agents [PDF]
Magnetic Resonance Imaging Clinics of North America, 2017 Miguel Ramalho, Joana Ramalho
exaly +2 more sources
Gadolinium-Based Contrast Agents [PDF]
, 2012 In neuroimaging, MRI sequences are obtained following intravenous administration of gadolinium-based contrast agents (GBCA) most commonly for the assessment of tumors, inflammatory conditions, and infectious processes. Contrast can also be used for MR angiography and perfusion imaging, although these studies can also be performed without contrast using
Kimball L. Christianson +2 more
+4 more sources
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. [PDF]
PLoS ONE, 2009 Liposomal-based gadolinium (Gd) nanoparticles have elicited significant interest for use as blood pool and molecular magnetic resonance imaging (MRI) contrast agents. Previous generations of liposomal MR agents contained gadolinium-chelates either within
Ketan B Ghaghada +5 more
doaj +1 more source